A novel tricarbonylmethane agent (CMC2.24) reduces human pancreatic tumor growth in mice by targeting Ras

Autor: Mallangada, Naveen A, Vargas, Joselin M, Thomas, Swaroopa, DiGiovanni, Matthew G, Vaeth, Brandon M, Nemesure, Matthew D, Wang, Ruixue, LaComb, Joseph F, Williams, Jennie L, Golub, Lorne M, Johnson, Francis, Mackenzie, Gerardo G

Publikováno v: Mallangada, NA; Vargas, JM; Thomas, S; DiGiovanni, MG; Vaeth, BM; Nemesure, MD; et al.(2018). A novel tricarbonylmethane agent (CMC2.24) reduces human pancreatic tumor growth in mice by targeting Ras. Molecular Carcinogenesis, 57(9), 1130-1143. doi: 10.1002/mc.22830. UC Davis: Retrieved from: http://www.escholarship.org/uc/item/5rr4x7bz
Molecular carcinogenesis, vol 57, iss 9

© 2018 Wiley Periodicals, Inc. Pancreatic Cancer (PC) is a deadly disease in need of new therapeutic options. We recently developed a novel tricarbonylmethane agent (CMC2.24) as a therapeutic agent for PC, and evaluated its efficacy in preclinical m

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::5776afed4c70c97ebfa1633ce86bc6f7
http://www.escholarship.org/uc/item/5rr4x7bz

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.